$IMMX 8-K SEC Filings

Filed On	Filing
30 Sep 2026	8-K: Other Events Immix Biopharma, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several underwriters named in Schedule I
29 Sep 2026	8-K: Regulation FD Disclosure; Other Events Immix Biopharma Announces 89% Complete Response Rate at Interim Update Across All NEXICART-2 Patients, with MRD-Negativity Indicating Potential to Reach up to 98% Complete Response Rate, Supporting Potential Best-in-Class Therapy for Rel...
20 Jul 2026	8-K: Other Events
29 May 2026	8-K: Submission of Matters to a Vote of Security Holders
21 May 2026	8-K: Other Events
21 May 2026	8-K: Regulation FD Disclosure; Other Events
30 Mar 2026	8-K: Regulation FD Disclosure; Other Events
25 Mar 2026	8-K: Entry into a Material Definitive Agreement
08 Dec 2025	8-K: Entry into a Material Definitive Agreement
08 Dec 2025	8-K: Regulation FD Disclosure; Other Events
26 Nov 2025	8-K: Other Events
08 Sep 2025	8-K: Entry into a Material Definitive Agreement; Unregistered Sales of Equity Securities +1 more
23 Jun 2025	8-K: Submission of Matters to a Vote of Security Holders
03 Jun 2025	8-K: Entry into a Material Definitive Agreement
26 Jul 2024	8-K: Other Events
22 Jul 2024	8-K: Changes in Registrant's Certifying Accountant
14 Jun 2024	8-K: Departure/Election of Directors or Officers; Compensation; Submission of Matters to a Vote of Security Holders
20 May 2024	8-K: Unregistered Sales of Equity Securities; Other Events
06 Feb 2024	8-K: Entry into a Material Definitive Agreement; Other Events
05 Feb 2024	8-K: Other Events

Comments